跳至主要内容
临床试验/RBR-8kyq7g
RBR-8kyq7g进行中(未招募)未知

Effects of adjunctive Mononitrate, a nitric oxide donor, in outpatients with a Schizophrenia diagnosis

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP0 个研究点开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 50Y(—)

入选标准

  • Patients of both sexes, age between 18 and 50 years, diagnosis of schizophrenia, in outpatient antipsychotic treatment without modifications in the last month and with symptoms present in the positive or negative dimensions.

排除标准

  • Presence of relevant medical condition, such as cardiovascular diseases, severe hypertension, renal failure, liver disease, hypothyroidism, hyponatremia, B12 hypovitaminosis, previous intracranial hypertension, epilepsy, pregnancy, breastfeeding). This also includes patients who have signs and symptoms suggestive of hypotension such as blurred vision, dizziness, pallor, and cold extremities. History of hypersensitivity to organic nitrates. Diagnosis of substance use disorder according to DSM criteria, except nicotine. Patients with severe psychiatric comorbidities and who are the focus of clinical care in the recruitment period, such as major depressive episode and obsessive compulsive disorder. Patients with clinical criteria for integral hospitalization.

研究者

发起方
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

相似试验